Can therapeutic drug monitoring of lorlatinib help us design the right CROWN?

Lung Cancer. 2024 Oct:196:107965. doi: 10.1016/j.lungcan.2024.107965. Epub 2024 Sep 23.
No abstract available

Publication types

  • Letter
  • Editorial

MeSH terms

  • Aminopyridines* / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Drug Monitoring* / methods
  • Humans
  • Lactams* / therapeutic use
  • Lactams, Macrocyclic* / therapeutic use
  • Lung Neoplasms* / drug therapy
  • Protein Kinase Inhibitors / therapeutic use
  • Pyrazoles* / therapeutic use

Substances

  • Lactams
  • Pyrazoles
  • lorlatinib
  • Aminopyridines
  • Lactams, Macrocyclic
  • Protein Kinase Inhibitors
  • Antineoplastic Agents